BrosMed Medical Announces CE Mark and Launch of Wedge™ Semi-complaint Scoring PTCA October 27th, 2017—BrosMed Medical announced CE Mark and Launched its Wedge™ Scoring PTCA Balloon for the treatment of percutaneous transluminal coronary angioplasty […]
July 12, 2013, BrosMed attended the 13th China Venture Capital & Private Equity Semi-Annual Forum, 2013. Benny Lee, the chairman of BrosMed, presented company’s medium-term strategy and equity trading plan. […]
Apr. 4th –Apr. 7th 2013, Welcome stop at B05 Hall 11 of BrosMed’s booth on EXPOMED 2013 in Istanbul, Turkey